Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The product is intended for scientific research, laboratory analysis and reference applications, and is not intended for consumption by humans or animals
More human studies are necessary to determine its safety profile
The pivotal Phase 2 trial (NCT04881760), published in The New England Journal of Medicine (Jastreboff et al., 2023), enrolled 338 adults with BMI 30 or higher
At the time of writing, FDA lists BPC-157 in Category 2 for certain compounding contexts and says compounded drugs containing BPC-157 may involve peptide-related impurities and API characterization complexities, and that the agency lacks sufficient information to know whether the drug would cause harm when administered to humans
It does not make eating less feel easier, does not reduce cravings, and does not change food preferences
Usage under expert guidance is crucial
US$ 21.68
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 21.23
US$ 29.79
